RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure

• click to rate

  Posted by Two Blokes Fri at 5:45 PM - Filed in Stock - 1 view
  
  Rocket Pharmaceuticals jumps 16.8% as FDA grants RMAT status to RP-A601 on positive phase I heart disease data.